Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Rxi Pharmaceuticals (RXII)

0.5417 -0.0129 (-2.3322%)

8/23/2017  2:54pm

Open:

0.5549

Pre. Close:

0.5546

High:

0.5572

Low:

0.5300

Volume:

102,377

Market Cap:

12.59M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.57 - 0.58

0.58 - 0.6

Low:

0.51 - 0.51

0.51 - 0.53

Close:

0.53 - 0.55

0.55 - 0.57

Technical analysis  (as of: 2017-08-23 2:39:44 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.71     One year: 0.77

Support:

Support1: 0.53    Support2: 0.44

Resistance:

Resistance1: 0.61    Resistance2: 0.66

Pivot:

0.58

Moving Averages:

MA(5): 0.56     MA(20): 0.59

MA(100): 0.62     MA(250): 0.97

MACD:

MACD(12,26): -0.02     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 16.18     %D(3): 25.73

RSI:

RSI(14): 38.68

52-Week:

High: 2.9300  Low: 0.5100  Change(%): -76.7

Average Vol(K):

3-Month: 20333  10-Days 3119

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
RXII has closed above bottom band by 11.6%. Bollinger Bands are 35.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 23 Aug 2017 18:56:15 GMT
Rxi Pharmaceuticals Corp (RXII) Moving -0.90% in Session

Wed, 21 Dec 2016 14:48:45 GMT
RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public ...

Wed, 08 Feb 2017 12:06:26 GMT
RXi Pharmaceuticals to Present at Leading Investor and Healthcare Conferences

Thu, 12 Jan 2017 14:58:55 GMT
RXi Pharmaceuticals Acquires MirImmune For Cancer Immunotherapy Prospects

Thu, 15 Jun 2017 11:15:00 GMT
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating RXi ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

23.25

Shares Float (M)

18.63

% Held by Insiders

% Held by Institutions

Shares Short (K)

2160

Shares Short Prior Month (K)

2260

Stock Financials

EPS

-1.390

EPS Est. Current Year

-1.770

EPS Est. Next Year

-0.570

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

0.370

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-79.3

Return on Equity (ttm)

-229.7

Qtrly Rev. Growth

Gross Profit (p.s.)

0.001

Sales Per Share

EBITDA (p.s.)

-0.404

Qtrly Earnings Growth

Operating Cash Flow (M)

-8.09

Levered Free Cash Flow (M)

-4.54

FoxReading.com

Valuation

P/E

-0.39

P/E Growth Ratio

-0.02

P/BV

1.47

P/S

P/CF

-1.56

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-04-18

Last Split Ratio

0.033

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.